Answers are grounded in this paper and cite their sources.
Pulmonary complications are common after hematopoietic stem cell transplantation (HSCT) and a major threat to the survival of the HSCT recipient.1 Pulmonary function tests (PFTs) are part of the evaluation before allogeneic HSCT. After transplantation, PFTs can help to diagnose pulmonary toxicities from chemotherapy or radiation therapy and in diagnosing specific syndromes after HSCT such as bronchiolitis obliterans syndrome (BOS). Given the frequency and negative prognostic implications of pulmonary complications of HSCT developing,2 postoperative guidelines for HSCT recommend that patients undergo pulmonary function monitoring at least annually after HSCT.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: